Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease.

MLA

Wei Mao, et al. “Rationale and Design of the Helping Ease Renal Failure with Bupi Yishen Compared with the Angiotensin II Antagonist Losartan (HERBAAL) Trial: A Randomized Controlled Trial in Non-Diabetes Stage 4 Chronic Kidney Disease.” BMC Complementary & Alternative Medicine, vol. 15, no. 1, Sept. 2015, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12906-015-0830-1.

APA

Wei Mao, Lei Zhang, Chuan Zou, Chuang Li, Yifan Wu, Guobin Su, Xinfeng Guo, Yuchi Wu, Fuhua Lu, Qizhan Lin, Lixin Wang, Kun Bao, Peng Xu, Daixin Zhao, Yu Peng, Hui Liang, Zhaoyu Lu, Yanxiang Gao, Xina Jie, & La Zhang. (2015). Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney disease. BMC Complementary & Alternative Medicine, 15(1), 1–10. https://doi.org/10.1186/s12906-015-0830-1

Chicago

Wei Mao, Lei Zhang, Chuan Zou, Chuang Li, Yifan Wu, Guobin Su, Xinfeng Guo, et al. 2015. “Rationale and Design of the Helping Ease Renal Failure with Bupi Yishen Compared with the Angiotensin II Antagonist Losartan (HERBAAL) Trial: A Randomized Controlled Trial in Non-Diabetes Stage 4 Chronic Kidney Disease.” BMC Complementary & Alternative Medicine 15 (1): 1–10. doi:10.1186/s12906-015-0830-1.